Eli Lilly Bolsters Genetic Medicine Pipeline With $3.2 Billion Kelonia Therapeutics Acquisition INDIANAPOLIS — In a decisive move to dominate the next frontier of oncology, Eli Lilly has announced the acquisition of Kelonia Therapeutics for $3.2 billion, signaling a massive bet on the future of internal genetic reprogramming. The deal secures a promising in vivo … Read more
The Gut-Brain Connection: New Breakthroughs in Fighting Cognitive Decline and Alzheimer’s Medical science is witnessing a paradigm shift as researchers uncover a startling reality: the fight against dementia may not begin in the skull, but in the stomach. Recent findings regarding the gut-brain axis and cognitive decline are redefining how we approach neurodegenerative diseases. In … Read more
The Future of Hair: Revolutionary Therapies Offer Hope for Millions For centuries, hair loss has been a source of distress and self-consciousness for individuals worldwide. But now, a wave of groundbreaking research and therapeutic advancements suggests that baldness may not be an inevitable fate. From innovative cell therapies to a deeper understanding of alopecia’s complexities, … Read more